Vaccines
- IDSA leads over 90 organizations on COVID-19 vaccine letter to FDA:
Organizations representing clinicians, scientists, patients, health care facilities and others urge FDA to ensure that a COVID-19 vaccine is only authorized or licensed when it meets FDA’s existing high standards of safety and efficacy. - Letter to the National Academy of Medicine’s Committee on Equitable Allocation of Vaccine for the Novel Coronavirus, 9/4/20
IDSA comments on the recently released discussion draft of the Preliminary Framework for Equitable Allocation of COVID-19 Vaccine. - IDSA PIDS Letter on Pharmacists Vaccinating Children
IDSA and PIDS emphasize the importance of increasing vaccination rates and comprehensive pediatric care. - Advisory Committee on Immunization Practices Meeting Summary
CDC’s Advisory Committee on Immunization Practices (ACIP) discussed several COVID-19 vaccine candidates undergoing clinical study at its latest meeting - Letter Urging Inclusion of People Living With HIV in COVID-19 Vaccine Trials, 7/29/20
IDSA and HIVMA writes to HHS Operation Warp Speed leadership on including PLWH and medically underserved communities in vaccine trials. - Recommendations for Increasing Vaccination Rates in Children and Adults During the COVID-19 Pandemic
IDSA, HIVMA, SHEA & PIDS recommend policies to increase immunization rates.
ID Workforce
- Telehealth Stakeholder Letter to Congress, 6/29/20
IDSA joins over 300 organizations urging Congress to make current telehealth flexibilities permanent. - Where is the ID in COVID-19?
A study published in Clinical Infectious Diseases that found that 80% of counties with highest number of COVID-19 cases at the time of the study had below average ID physicians or no ID physicians at all. - Strengthening the Infectious Diseases Workforce to Combat COVID-19 and Future Pandemics
IDSA policy brief on ID workforce challenges and policy recommendations to address them. - Letter on Loan Forgiveness for Frontline Health Workers Act, 5/12/20
IDSA and HIVMA letter endorsing legislation to provide loan forgiveness for ID/HIV physicians and other frontline health care professionals. - IDSA and HIVMA Letter to Department of State, 4/16/20
Letter urging Department of State and U.S. Citizenship and Immigration Services to ensure foreign-born international medical graduates are able to respond to the COVID-19 pandemic. - Outbreak Activation Reimbursement for Providers on the Frontlines of the COVID-19 Response
IDSA’s request to Congress for a Medicare coding pathway for outbreak activation activities.
Funding/Congressional Response Legislation
- Priorities for Next COVID-19 Response Legislation, 7/24/20
IDSA and HIVMA outline key issues for the next Congressional COVID-19 response bill. - Priorities for Next COVID-19 Response Bill, 7/13/20
IDSA and HIVMA list priorities for Congress as it develops CARES Act follow-up legislation.
Public Health
- Letter to the Biden Presidential Campaign on Addressing COVID-19, 8/13/20
IDSA and HIVMA offer information, resources and evidence-based advice on confronting the pandemic and protecting public health. - Letter to the Trump Presidential Campaign on Addressing COVID-19, 8/13/20
IDSA and HIVMA offer information, resources and evidence-based advice on confronting the pandemic and protecting public health. - Letter Urging Administration to Reverse Course on COVID-19 Patient Data Reporting Change, 7/17/20
More than 100 organizations urge the Administration to protect data integrity, keep public health data public and invest in CDC data reporting. - IDSA Comments on White House Blueprint for Testing & Rapid Response, 5/8/20
Letter offering evidence-based key considerations.
Health Disparities
- COVID-19 Policy Brief: Disparities Among Immigrant Populations in the United States
This policy brief focuses on health and immigration policies that put immigrant populations—especially undocumented immigrants—at significant risk of contracting COVID-19 and experiencing adverse health outcomes due to COVID-19. - COVID-19 and Health Disparities in the United States
Issue brief from IDSA and HIVMA with policy recommendations. - COVID-19 and Health Disparities: The Impact on Native American Communities
Recommendations for addressing disparities among Native American communities. - COVID-19 and Health Disparities: The Impact on Black/African American Communities
Recommendations for addressing disparities among Black/African American communities. - COVID-19 and Health Disparities: The Impact on Latinx Communities
Recommendations for addressing disparities among Latinx communities. - Strengthening the Response to COVID-19 in Correctional Facilities
IDSA and HIVMA recommendations for preventing and responding to outbreaks in correctional facilities. - Letter of Support for the Minority Community Public Health Emergency Response Act, 8/13/20
IDSA and HIVMA support H.R.7456, which would provide resources to communities with high percentages of people of color impacted by COVID-19. - Group Letter Urging Action on PPE, Testing & Supplies to Protect Vulnerable Populations, 7/23/20
IDSA, HIVMA, and other organizations convened by the National Medical Association and the Rainbow PUSH Coalition urge federal action on PPE, COVID-19 testing and supplies.
Diagnostics
- Letter to HHS re 8/20/20 rescission of LDT guidances
IDSA offers questions and recommendations to HHS following their announcement to rescind existing FDA premarket review requirements for laboratory developed tests.
Public Safety
- What the Experts Say About COVID-19 Risks
IDSA-developed infographic categorizing the risk level of common activities. - Guidelines for Healthy In-Person Voting
Guidelines developed jointly by IDSA and Brennan Center for Justice for minimizing the risk of SARS-CoV-2 transmission at polling locations. - Letter Urging Governors to Implement State Mask Requirements, 8/10/20
IDSA and HIVMA emphasize to the National Governors Association the importance of state mask requirements to prevent transmission of COVID-19. - Letter to White House Coronavirus Task Force on Mask Requirements, 8/5/20
IDSA and HIVMA advocate policy options to significantly increase mask use nationwide. - How to Stay Safe During Re-opening
Infographic developed by IDSA for the general public. - Reopening Safely: Help Stop the Spread of COVID-19
Public health best practices and resources compiled by IDSA and HIVMA. - Face Coverings and Masks: Advice and Information for the General Public
Printable one-page document created by IDSA and HIVMA.
Pandemic Preparedness
- Letter to HHS on Health System Resilience, 7/8/20
IDSA and HIVMA recommendations related to the ID/HIV workforce, PPE, testing capacity, masks and physical distancing, health disparities, contact tracing, research, and immunizations. - IDSA and HIVMA Response to Senate Health Committee “Preparing for the Next Pandemic” White Paper
Recommendations to inform the development of pandemic preparedness legislation. - Initial Lessons Learned: Recommendations to Prepare for a Fall Surge of COVID-19 Cases
Preparedness policy recommendations from IDSA, HIVMA, and SHEA - IDSA Comments on CURES 2.0 Concept Paper and COVID-19, 5/6/20
Letter to Hill leaders offering feedback on policy proposals relevant to pandemic preparedness and response.
Patient Care
- Letter to Vice President Pence and Sec Azar on Access to Remdesivir, 7/14/20
IDSA and HIVMA urge the administration to use every authority it has to ensure an adequate supply of remdesivir in the U.S. and worldwide. - Letter Asking Ambassador Birx for Remdesivir Distribution Discussion, 5/14/20
IDSA and HIVMA letter requesting a meeting with White House Coronavirus Task Force Coordinator on continuing uncertainty surrounding access. - Ensuring Fair and Equitable Distribution of Remdesivir, 5/6/20
IDSA and HIVMA letter to the White House Coronavirus Task Force. IDSA and HIVMA Letter to Congress on Medical Supply Chain, 4/23/20
Letter in support of H.R. 6390, a bill to require emergency production of medical equipment.
Antimicrobial Resistance
- Letter to Congress on Addressing Antimicrobial Resistance in COVID-19 Response, 8/5/20
Joint letter urging Congress to address antimicrobial resistance in forthcoming COVID-19 legislation. - IDSA-led Stakeholder Letter on AMR and Preparedness
Stakeholders highlight the need to address AMR as part of broader preparedness efforts. - Strategies to Address Antimicrobial Drug Shortages, 6/1/20
Issue brief on current antimicrobial drug shortages and potential policy interventions.
Global Health
- Infectious Diseases Leaders Respond to President Trump’s Defunding of the World Health Organization, 4/15/20
A joint statement from IDSA, HIVMA, SHEA, PIDS, and SIDP. - Recommendations for U.S. Efforts to Strengthen Global Vaccination Coverage During the COVID-19 Pandemic
IDSA and HIVMA recommend policies to strengthen global immunization infrastructure.
Research
- Letter of Concern Regarding EcoHealth Alliance Grant Termination, 5/11/20
IDSA, HIVMA, PIDS and the American Society of Tropical Medicine and Hygiene express concern about a coronavirus-focused NIH grant’s termination. - IDSA Outlines Key COVID-19 Research Questions and Recommendations
Research recommendations to drive the advancement of evidence-based prevention, diagnostics, and treatment.